Episurf Medical AB (publ) (STO:EPIS.B)
Sweden · Delayed Price · Currency is SEK 0.0739
-0.0026 (-3.40%)
Sep 25, 2026, 12:47 PM CET
Episurf Medical AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 26.1 | 13.5 | 13 | 10.3 | 6.6 | 6.5 |
| 26.1 | 13.5 | 13 | 10.3 | 6.6 | 6.5 | |
Revenue Growth | 123.08% | 3.85% | 26.21% | 56.06% | 1.54% | 30.00% |
Cost of Revenue | 13.5 | 10.1 | 9.9 | 61.6 | 36.2 | 35 |
Gross Profit | 12.6 | 3.4 | 3.1 | -51.3 | -29.6 | -28.5 |
Selling, General & Admin | 30.9 | 30.9 | 36.5 | 46.6 | 40.3 | 34 |
Other Operating Expenses | 21.9 | 22.2 | 34.8 | -9.8 | -0.3 | -0.4 |
Operating Expenses | 60.9 | 61.2 | 80.3 | 45.5 | 47.4 | 41 |
Operating Income | -48.3 | -57.8 | -77.2 | -96.8 | -77 | -69.5 |
Interest Expense | -15.3 | -0.6 | -1 | -0.9 | -0.7 | -0.2 |
Interest & Investment Income | 6.8 | 0.5 | 2.2 | 3.1 | 0.5 | 0.4 |
Other Non Operating Income (Expenses) | -56.2 | - | 0.1 | 0.1 | - | -0.1 |
EBT Excluding Unusual Items | -113 | -57.9 | -75.9 | -94.5 | -77.2 | -69.4 |
Other Unusual Items | - | - | - | - | - | 0.1 |
Pretax Income | -295.5 | -57.9 | -75.9 | -94.5 | -77.2 | -69.3 |
Income Tax Expense | -0.3 | 0.3 | 0.1 | 0.3 | 0.1 | - |
Net Income | -295.2 | -58.2 | -76 | -94.8 | -77.3 | -69.3 |
Net Income to Common | -295.2 | -58.2 | -76 | -94.8 | -77.3 | -69.3 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 2,808 | 987 | 479 | 314 | 267 | 227 |
Shares Outstanding (Diluted) | 2,808 | 987 | 479 | 314 | 267 | 227 |
Shares Change | 339.86% | 105.90% | 52.50% | 17.84% | 17.67% | 39.80% |
EPS (Basic) | -0.11 | -0.06 | -0.16 | -0.30 | -0.29 | -0.31 |
EPS (Diluted) | -0.11 | -0.06 | -0.16 | -0.30 | -0.29 | -0.31 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -31.1 | -55.3 | -71.4 | -84.8 | -69.5 | -59.8 |
Free Cash Flow Per Share | -0.01 | -0.06 | -0.15 | -0.27 | -0.26 | -0.26 |
Gross Margin | 48.28% | 25.19% | 23.85% | - | - | - |
Operating Margin | -185.06% | -428.15% | -593.85% | -939.81% | -1166.67% | -1069.23% |
Profit Margin | -1131.03% | -431.11% | -584.62% | -920.39% | -1171.21% | -1066.15% |
Free Cash Flow Margin | -119.16% | -409.63% | -549.23% | -823.30% | -1053.03% | -920.00% |
EBITDA | -47.6 | -55.3 | -74.1 | -94.1 | -74.4 | -66.6 |
D&A For EBITDA | 0.7 | 2.5 | 3.1 | 2.7 | 2.6 | 2.9 |
EBIT | -48.3 | -57.8 | -77.2 | -96.8 | -77 | -69.5 |
Revenue as Reported | 22.8 | 22.8 | 20.7 | 20.1 | 18.2 | 13.8 |